Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window
Closure of Trading Window30-06-2021
30-06-2021
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 30, 2021 for Akash Farms LLP30-06-2021
Nath Bio-Genes (India) Ltd - 537291 - Intimation For Book Closure For AGM And Dividend
Intimation for Book Closure for AGM and Dividend26-06-2021
Nath Bio-Genes (India) Ltd - 537291 - Board recommends Dividend (AGM on August 27, 2021)
Nath Bio-Genes (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 24, 2021, inter alia, has recommended dividend for financial year 2020-21 of Rs. 2/- (i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company.24-06-2021
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Audited Financial Results as on 31st March 2021.24-06-2021
Nath Bio-Genes (India) Ltd - 537291 - Book Closure For Upcoming Annual General Meeting
Book closure for upcoming Annual General Meeting24-06-2021
Nath Bio-Genes (India) Ltd - 537291 - Outcome Of Board Meeting Held On 24Th June 2021
Outcome of Board Meeting held on 24th June 202124-06-2021
Nath Bio-Genes (India) Ltd - 537291 - Audited Financial Results As On 31St March 2021
Audited Financial Results as on 31st March 202124-06-2021
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Conference call to be held on 25th June 2021, at 11.00 am.23-06-2021